SecFilingDex

CalciMedica, Inc.

44 SEC EDGAR filings indexed (CIK 0001534133) across 14 form types.

Filing profile

CalciMedica, Inc. (CALC) has 44 SEC filings indexed on SecFilingDex, across 14 form types filed over roughly 2 years, from October 30, 2024 to August 24, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 26 of these filings were disclosed in the twelve months to August 24, 2026. 6 of the 44 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 8Form 4Insider transaction · within 2 business days of transaction
  • 88-KMaterial event · event-driven
  • 610-QQuarterly report · quarterly
  • 4Form 3Initial insider ownership · within 10 days of becoming an insider
  • 4424B5Prospectus supplement · event-driven
  • 3SC 13G/A5%+ passive stake · event-driven
  • 2DEF 14AProxy statement · annual (pre-meeting)
  • 210-KAnnual report · annual
  • 2DEFA14ASEC filing
  • 1PRE 14ASEC filing
  • 110-K/AAnnual report · annual
  • 1SC 13D5%+ activist stake · event-driven (within 10 days)
  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
  • 1Form 4/AInsider transaction · within 2 business days of transaction

Profile derived from 44 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1534133&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.